Henry Whitfield - An integral model for overcoming relapse and inc effectiveness in Psychedelic...

Psychedelic-assisted therapy relies on tools that can effectively address the high rates of relapse seen in clinical trials. Current standardized research approaches like randomized controlled trials often prioritize group-level outcomes over the individual nuances that psychotherapists manage. An integral model incorporates Acceptance and Commitment Therapy along with other therapeutic modalities to better support the unique psychological structures of individual patients. Clinicians may enhance patient outcomes by focusing on therapeutic processes that allow for the continued processing and integration of peak experiences. Using techniques that allow patients to re-access peak states can solidify therapeutic benefits. Incorporating a nuanced understanding of these processes can help clinicians move toward more precise, personalized approaches in psychedelic-assisted care.